EP Patent

EP4482835A1 — Process for purification of linagliptin

Assigned to KRKA dd · Expires 2025-01-01 · 1y expired

What this patent protects

The present invention relates to a process for purification of linagliptin. Furthermore, the present application pertains to linagliptin purified by this process, as well as to a novel compound and its use.

USPTO Abstract

The present invention relates to a process for purification of linagliptin. Furthermore, the present application pertains to linagliptin purified by this process, as well as to a novel compound and its use.

Drugs covered by this patent

Patent Metadata

Patent number
EP4482835A1
Jurisdiction
EP
Classification
—
Expires
2025-01-01
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.